Andere talen Metropolis Healthcare Limited

Aandelen

METROPOLIS

INE112L01020

slotkoers NSE India S.E. Andere beurzen 00:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.740 ^INR	-0,38%		-3,38%	+3,67%

11/04	Metropolis Healthcare boekt 10% hogere totale omzet in fiscaal vierde kwartaal	MT
05/02	Metropolis Healthcare's geconsolideerde nettowinst daalt in het derde kwartaal	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Metropolis Healthcare Books 10% Increase in Fiscal Q4 Overall Revenue	11/04
Metropolis Healthcare Limited Announces Consolidated Revenue Results for the Fourth Quarter Ended March 31, 2024	10/04
Metropolis Healthcare's Consolidated Net Profit Declines in Fiscal Q3	05/02
Metropolis Healthcare Limited Announces Management Changes	02/02
Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02
Metropolis Healthcare Limited Approves and Declares Payment of an Interim Dividend for the Financial Year 2023-24	04/11
Crisil Keeps AA- Rating on Metropolis Healthcare's Bank Loans; Revises Outlook to Stable	05-10-23
Metropolis Healthcare Limited Announces the Cessation of Milind Sarwate as an Independent Director, Chairman/Member of Audit Committee, Risk Management Committee and Corporate Social Responsibility Committee, Effective September 06, 2023	06-09-23
Metropolis Healthcare Limited Appoints Mohan Menon as Chief Marketing Officer	07-08-23
Metropolis Healthcare's Consolidated Profit Drops in Fiscal Q1	04-08-23
Metropolis Healthcare to Seek Smaller Bolt-On Acquisitions	03-08-23
Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	02-08-23
Metropolis Healthcare Limited Appoints Neha Shah as Interim Company Secretary	20-06-23
Metropolis Healthcare Seeks Acquisitions	17-05-23
Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	16-05-23
India's Dr. Lal PathLabs reports decline in Q4 profit	11-05-23
Metropolis Healthcare Limited Approves Reconstitution of Board Committees	01-04-23
Metropolis Healthcare's Consolidated Profit Slides in Fiscal Q3; EPS, Revenue Miss Estimate	13-02-23
Metropolis Healthcare Limited Declares Interim Dividend for the Financial Year 2022-23	10-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Metropolis Healthcare Limited

Aandelen

METROPOLIS

INE112L01020

Andere talen

Filters